Geneos Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $77.6K | Sell |
|
|||||
|
2025
Q1 | $124K | Buy |
|
|||||
|
2024
Q4 | $11.1K | Hold |
|
|||||
|
2024
Q3 | $12.9K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $146K | Sell |
|
|||||
|
2022
Q1 | $271K | Sell |
|
|||||
|
2021
Q4 | $292K | Buy |
|
|||||
|
2021
Q3 | $324K | Buy |
|
|||||
|
2021
Q2 | $288K | Sell |
|
|||||
|
2021
Q1 | $251K | Sell |
|
|||||
|
2020
Q4 | $276K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1K | Sell |
|
|||||
|
2016
Q4 | $1K | Hold |
|
|||||
|
2016
Q3 | $2K | Buy |
|